eric hollander

Professor

Albert Einstein College of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Eric Hollander is a Professor at the Albert Einstein College of Medicine, located in the United States. His research interests focus on anxiety disorders, obsessive-compulsive disorders, and neurodevelopmental disorders, including autism spectrum disorder. Recent publications include studies on cognitive inflexibility in children with autism, the role of oxytocin in neurodevelopmental conditions, and the efficacy of benzodiazepines in treating anxiety-related issues.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (4)

naomi fineberg

University of Hertfordshire

UNITED KINGDOM

View details

Giampaolo Perna

Humanitas University

ITALY

View details

Beatrice Benatti

University of Milan

ITALY

View details

Borwin Bandelow

Prof. Dr., Senior Scientist

University Medical Center Göttingen

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

eric hollander

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

An update from the WPA Section on Anxiety and Obsessive-Compulsive Disorders

Cognitive inflexibility and immunome biomarkers in children with autism spectrum disorder

Oxytocin in neurodevelopmental disorders: Autism spectrum disorder and Prader-Willi syndrome

Revisiting benzodiazepines (GABA Enhancers):A transdiagnostic and precision medicine approach

Yale-Brown Obsessive-Compulsive Scale Modified for Body Dysmorphic Disorder: Factor structure and construct validity of subfactors

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part I: Anxiety disorders

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders – Version 3. Part II: OCD and PTSD

Lessons from a multicentre, international, large sample size analysis of patients with obsessive-compulsive disorders: an overview of the ICOCS Snapshot studies

Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorder

The role of ketogenic therapy in developmental disorders

Collaborators (4)

naomi fineberg

Giampaolo Perna

Beatrice Benatti

Borwin Bandelow

Make your next move.